It really wouldn't necessarily be a question within the purview of the Public Health Agency of Canada. I could speak to it in terms of the committee looking at evidence for this being associated with mefloquine, and there has been no evidence sufficient to support that.
As well, post-traumatic stress disorder is considered as a very separate entity from toxicity that might be associated with medication, so the two aren't well aligned.